France begins recall of ex-Genopharm products as Alkopharm takes over
This article was originally published in Scrip
Executive Summary
The French authorities have begun the recall of medicines that were distributed by Genopharm before it was dissolved following the suspension of its operations and those of its sister company Alkopharm on 20 December 2011. Genopharm's assets have been transferred to Alkopharm, which is now responsible for the products concerned.
You may also be interested in...
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.